Posted by | April 21, 2012 16:25 | Filed under: Top Stories

Studies show hope that anxiety and fear can be reduced.

When the research was completed in 2008 — (and published in the Archives of General Psychiatry last year) — the results showed that administering psilocybin to terminally ill subjects could be done safely while reducing the subjects’ anxiety and depression about their impending deaths…

Dr. John Halpern, head of the Laboratory for Integrative Psychiatry at McLean Hospital in Belmont Mass., a psychiatric training hospital for Harvard Medical School, used MDMA — also known as ecstasy — in an effort to ease end-of-life anxieties in two patients with Stage 4 cancer. And there are two ongoing studies using psilocybin with terminal patients, one at New York University’s medical school, led by Stephen Ross, and another at Johns Hopkins Bayview Medical Center, where Roland Griffiths has administered psilocybin to 22 cancer patients and is aiming for a sample size of 44. “This research is in its very early stages,” [researcher Charles]Grob told me earlier this month, “but we’re getting consistently good results.

Click here for reuse options!
Copyright 2012 Liberaland
By: Alan

Alan Colmes is the publisher of Liberaland.